Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001601923-14-000001
Filing Date
2014-03-13
Accepted
2014-03-13 12:42:20
Documents
1
Effectiveness Date
2014-03-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7051
  Complete submission text file 0001601923-14-000001.txt   8089
Mailing Address 11555 SORRENTO VALLEY ROAD SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SAN DIEGO CA 92121 619-788-2383
Theragene Pharmaceuticals, Inc. (Filer) CIK: 0001601923 (see all company filings)

EIN.: 450604743 | State of Incorp.: CA | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-213512 | Film No.: 14690259